Ally Bridge Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-201,752
| Closed | -$4.8M | – | 22 |
|
|
2023
Q2 | $4.8M | Buy |
+201,752
| New | +$4.8M | 5.81% | 7 |
|
|
2022
Q3 | – | Sell |
-496,012
| Closed | -$5.74M | – | 46 |
|
|
2022
Q2 | $5.74M | Hold |
496,012
| – | – | 5.23% | 8 |
|
|
2022
Q1 | $9.17M | Sell |
496,012
-108,762
| -18% | -$2.01M | 6.8% | 6 |
|
|
2021
Q4 | $12M | Sell |
604,774
-300,204
| -33% | -$5.93M | 4.18% | 8 |
|
|
2021
Q3 | $14.9M | Buy |
904,978
+45,068
| +5% | +$741K | 4.38% | 8 |
|
|
2021
Q2 | $15.7M | Buy |
859,910
+179,142
| +26% | +$3.28M | 3.91% | 9 |
|
|
2021
Q1 | $11.4M | Buy |
+680,768
| New | +$11.4M | 2.18% | 12 |
|